Hypodermic Needles Market Size | Global Research Report 2028

Market Insights

The global hypodermic needles market garnered US$ 3,519.53 million in 2021 and is speculated to account for US$ 5,529.28 million by 2028, expanding at a CAGR of 6.7% during 2021–2028.

The increasing prevalence of chronic diseases and surging demand for vaccines are the potential parameters assisting the market growth while the availability of alternatives hamper the expansion of global hypodermic needles market.

The high prevalence of blood-borne diseases, active government participation to implement stringent regulations, increasing demand for injectable drugs and vaccines, and untapped potential in the emerging economies are the primary elements driving the growth of safety needles market. Key market players have been focusing on organic strategies such as product launch and expansions and also involved in inorganic developments such as collaborations and partnerships to enhance their regional dominance. The organic developments account for 60% of the strategic growth and the inorganic activities contributes to 40% of the total organizational development.

Regionally, North America held the major share of the global hypodermic needles market and is likely to retain its dominance throughout the forecast period. Asia Pacific is likely to spur with the highest CAGR over the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Global Hypodermic Needles Market: Strategic Insights

Global Hypodermic Needles Market

• 
  CAGR (2021 - 2028)

  6.7%
• Market Size 2021
  US$ 3.52 Billion
• Market Size 2028
  US$ 5.53 Billion

Market Dynamics

GROWTH DRIVERS

• XXXXXXX
• XXXXXXX
• XXXXXXX

FUTURE TRENDS

• XXXXXXX
• XXXXXXX
• XXXXXXX

OPPORTUNITIES

• XXXXXXX
• XXXXXXX
• XXXXXXX

Key Players

• EXELINT International Co
• Terumo Corporation
• BD
• B Braun Melsungen AG
• Catalent Inc
• Cardinal Health Inc
• Vita Needle Company
• Connecticut Hypodermics Inc
• Vygon

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Type

• Safety Needles and Non-Safety Needles

Application

• Drug Delivery
• Vaccination
• Blood Specimen Collection

End-Users

• Diagnostic Centers
• Hospitals and Clinics
• Home Health Care

Usage

• Disposable and Reusable

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

COVID-19 Impact

The Enormous Demand for Needles and Syringes During the Pandemic Surged the Growth of the Global Hypodermic Needles Market

The global COVID-19 pandemic led to increased hospital admissions followed by tests and medications that spurred the growth of market growth. The rise in COVID-19 vaccinations resulted in the enormous demand for needles and syringes. The vaccine campaign highlighted the utility of needles. Major market players capitalized the opportunity to quench the unprecedented demand for single-use needles. The pandemic necessitated the rapid vaccine development for curbing the disease. The vaccines approved for COVID-19 prevention were administered intramuscularly and subcutaneously using hypodermic needles. Several manufacturers maintained the robust supply chain to meet the requirement for continuous vaccination during the pandemic.

In January 2021, BD distributed 800 million syringes and needles to various hospitals in the US, as the company worked closely with Coronavirus Task Force, the US department of Health and Human Services. The hypodermic needles market in Europe witnessed a substantial growth due to highest number of COVID cases reported in Italy, Germany, France, Spain, and the UK. In July 2020, BD received a huge order of 65 million needles and syringes from the UK government to support country’s vaccination efforts. In Asia Pacific, pandemic hit the global hypodermic needles market moderately. Low-income countries in the region faced the shortage of healthcare infrastructure and supply-chain disruption. However, the market players were engrossed in medical developments seeing the demand for hypodermic needles. Misawa Medical Industry developed ‘low dead space needles’ that can reduce the quantity of medicinal liquid left in the syringe.

Future Trends

Technological Advancements in the Design of Hypodermic Needles

Pharmaceutical industry has been witnessing a large number of advanced interventions to treat several chronic diseases.There has been a greater need for devices that can allow patients or non-clinicians to administer injectable medications safely. Needle-free jet injector is one of the alternatives, but it is relatively expensive and less feasible for wide distribution. Hence, integrating advanced technology to make hypodermic needles more ergonomic became essential. In August 2020, scientists at MIT developed a prototype hypodermic needle with a syringe incorporating two barrels containing viscous medication and biocompatible lubricating fluid. Several manufacturers are working on precision-engineered needles and needlestick prevention technologies to excel in challenging applications. Most companies are providing safe designs and less painful injections to ensure therapeutic success.Hypodermic needles are undergoing controlled manufacturing and robust inspection for quality assurance.

Drivers

Increasing Prevalence of Chronic Diseases

Chronic diseases such as diabetes, CVDs, autoimmune disorders, and various types of cancer stands among the leading causes of death and disability.According to the Center for Disease Control and Prevention (CDC), around 6 out of 10 people suffered from at least one chronic disease in the US in 2019. Cardiovascular disorders cause high rate of mortality across the world with an estimated 17.9 million death cases every year. Diabetes is another life-threatening chronic disease with no functional cure. The exogenous insulin is usually administered to diabetic patients through a subcutaneous route. The wide acceptance of hypodermic needles for insulin delivery, enabling self-administration and accurate dosing drives the hypodermic needles market. Also, most biotherapeutics are injected using hypodermic needle injections as they provide a low-cost, rapid, and direct delivery of molecules.

Surging Demand for Vaccines

According to the WHO, around 90% injections are used for curative care worldwide. Immunization injections account for around 5%. An increasing demand for vaccines has surfaced as a key factor behind the growth of the global hypodermic needles market. Moreover, increased immunization coverage against preventable diseases provided by the Universal Immunization Program (UIP) is fueling the market growth. UNICEF’s joint efforts have made vaccines safer and more accessible. Apart from this, COVID-19 vaccine rollouts highlighted the critical role of needles, syringes, and other immunization tools. In July 2020, Smiths Medical partnered with the US government and received a US$ 20 million investment to increase the production of syringes and needles as a part of Operation Warp Speed Vaccine program.

Restraints

Availability of Alternatives

 The drawbacks of needle-based injections are well-known. Psychological resistance to self-injection or needle-phobia is documented across large demographic groups. In case of diabetes management, self-injection systems such as wearable injectors, pen-injectors, and needle-free injectors provide patients unmatched control over their treatment, thus restricting the growth of hypodermic needles market. The use of microneedles is gaining traction for being minimally invasive, pain alleviating, and infection-resistant, eventually curbing the concerned market growth. Also, hypodermic needles market is facing stiff competition created by needle-free injectors which are technically advanced and administer highly viscous drug products. Such alternatives posing challenges to the use of hypodermic needles are likely to hinder the market growth.

Market Segmentation

By Type

Clinical Benefits Over Conventional Syringes Spurred the Segmental Growth

The global hypodermic needles market, by type, is split into safety and non-safety needles. The former held the largest market share in 2021 and is anticipated to surge at the highest CAGR over the forecast period. A safety syringe has an in-built safety mechanism to lower the risk of needlestick injuries. Several countries have introduced regulations to ensure the use of safety syringes and prevent the re-use of needles. This helped expedite the use of safety syringes over conventional ones. Key players offering safety needles include BD and Cardinal Health. BD manufactures active and passive needle-based safety systems and Cardinal Health provides Monoject and Magellan safety needles and syringes.

Non-safety needles are low-cost and provide sterile injections with proper usage. The segmental growth can be attributed to the regular use in vaccination and the increasing birth rate in developing countries demanding more vaccines. The general use hypodermic needles manufactured by BD feature a regular bevel and wall that provide extra smooth vein entry with minimal drag.

By Application

Chronic Diseases and the Demand for Vaccination Upheld the Segment’s Dominance

Based on application, the global hypodermic needles market is segmented into drug delivery, vaccination, and blood specimen collection. The drug delivery segment dominated the market in 2021 with the largest revenue share and is projected to record the highest CAGR during the forecast period. The injectable mode of drug delivery system offers a large surface area for systematic absorption. The segmental growth can be accustomed to increasing prevalence of chronic diseases and rising demand for vaccines, insulin, human growth hormone, and modern medicines. Besides, biosimilar products and low-cost hypodermic needles are preferred choices for drug delivery. Several companies are conducting clinical trials on biosimilars that can potentially offer lucrative opportunities over the forecast period.

The vaccination segment was the second-largest market occupant in 2021 with a considerable demand and growth potential. Vaccination saves millions of lives every year. Governments across the world are heavily investing to alleviate the global disease burden, specifically with the aid of vaccines. Vaccination is often perceived as the first line of defence to shield any epidemic that can possibly lead to healthcare emergencies. Several global organizations in collaboration with regional government undertook initiatives to procure large quantity of syringes and needles for vaccination rollout. The segmental growth is ascribed to the growing epidemic potential, emphasis on therapeutic vaccines, and emerging markets.

Regional Insights

Geographically, the global hypodermic needles market is segmented into North America, Europe, Asia Pacific (APAC), South & Central America (SCAM), and Middle East & Africa (MEA).

North America held the largest market share in 2021 and is forecasted to retain its dominance till 2028. The region’s highest market occupancy is attributed to the aspects such as increasing blood donations, growing prevalence of infectious diseases, high-end infrastructure for hospitals and clinical laboratories, increasing surgical procedures, and the developments by major market players. In the US, the rising elderly population susceptible to various disorders and the growing cases of cancer, diabetes, chronic pain, and gastrointestinal diseases are likely to trigger the growth of hypodermic needles market. Cancer, diabetes, and autoimmune diseases are getting prevalent in Canada. Around 11 million Canadians are living with diabetes or prediabetic conditions. People in the country suffering from type-1 diabetes require frequent insulin doses, thereby bolstering the demand for syringes and hypodermic needles.

Asia Pacific hypodermic needles market is likely to expand with the highest CAGR over the forecast period. the rising adoption of hypodermic needles, developing healthcare infrastructure, extensive R&D activities, and the high prevalence of cancer, CVDs, and diabetes are the primary parameters soaring the market growth. In China, the market growth is largely driven by the growing prevalence of blood-borne diseases, chronic diseases, and consciousness about viable treatment options. Besides, the geriatric chunk in the country is likely to develop several chronic disorders. The Indian hypodermic needles market thrives on the rising chronic and lifestyle-associated diseases, growing elderly population, and increasing awareness towards medication and healthcare.

Lucrative Regions for Hypodermic Needles Market

Key Market Players:

• Exelint International, Co. (US)
• Terumo Corporation (Japan)
• BD (US)
• B.Braun Melsungen AG (Germany)
• Catalent Inc (US)
• Cardinal Health Inc (US)
• Vita Needle Company (US)
• Connecticut Hypodermics Inc (US)
• Vygon (France)
• Nipro Corp (Japan)
• Barber of Sheffield (UK)
• Retractable Technologies, Inc. (US)
• Air-Tite Products Co., Inc (US)

Hypodermic Needles Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Key Developments:

• December 2018:

  Terumo announced the European launch of Biosimilar using its PLAJEX pre-filled syringes.

• October 2021:

  BD hit 2 billion injection device milestone in the support of global COVID-19
  vaccination efforts.

• September 2019:

  B.Braun and Philips launched Onvision needle tip tracking, a breakthrough in real-time ultrasound guidance for regional anesthesia.

Report Coverage

The global hypodermic needles market research report provides detailed insights into the market in terms of size, share, trends, and forecasts. It delivers crisp and precise know-how of drivers, restraints, opportunities, segments, and industrial landscape. The COVID-19 impact analysis is discussed with the consequences followed in global and regional markets. A list of key market players with their respective developments in recent years has been reserved as a special mention.